Concourse Financial Group Securities, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$0.35 - $0.53 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$0.38 - $0.58 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	SELL	$0.38 - $0.58 $3 - $4	-8 Closed	0 $0
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $6 - $15	8 New	8 $0
Q4 2022 Jan 30, 2023	BUY	$1.41 - $2.5 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$1.66 - $2.79 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	SELL	$1.44 - $3.98 $423 - $1,170	-294 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.97 - $5.2 $650 - $1,138	-219 Reduced 42.69%	294 $1,000
Q3 2021 Nov 09, 2021	SELL	$7.16 - $9.69 $21,480 - $29,070	-3,000 Reduced 85.4%	513 $4,000
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $3,195 - $5,145	513 Added 17.1%	3,513 $32,000
Q4 2020 Feb 02, 2021	BUY	$8.5 - $12.85 $22,423 - $33,898	2,638 Added 728.73%	3,000 $27,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $1,512 - $4,273	158 Added 77.45%	362 $4,000
Q2 2020 Aug 13, 2020	SELL	$7.14 - $31.69 $5,683 - $25,225	-796 Reduced 79.6%	204 $5,000
Q1 2020 May 13, 2020	BUY	$2.98 - $14.09 $2,980 - $14,090	1,000 New	1,000 $7,000
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$2.05 - $3.02 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.29 - $4.1 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.92 - $5.58 $0 - $0	0 New	0 $0

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account